KEGG   DISEASE: Smith-Kingsmore syndrome
Entry
H01928                      Disease                                
Name
Smith-Kingsmore syndrome;
Macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome
Description
Smith-Kingsmore syndrome (SKS), also known as macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome (MINDS syndrome), is a rare autosomal dominant disorder. Heterozygous mutations in MTOR gene have been shown to underlie SKS. The most consistent findings in SKS are intellectual disability (ID), developmental delay, megalencephaly, and seizures. There is moderate clinical variability, ranging from patients with macrocephaly, mild ID, and no convulsions, to severe forms in patients with intractable epilepsy, megalencephaly, severe ID, and autistic spectrum disorder.
Category
Congenital malformation
Brite
Human diseases in ICD-11 classification [BR:br08403]
 20 Developmental anomalies
  LD90  Conditions with disorders of intellectual development as a relevant clinical feature
   H01928  Smith-Kingsmore syndrome
Pathway-based classification of diseases [BR:br08402]
 Signal transduction
  nt06522  mTOR signaling
   H01928  Smith-Kingsmore syndrome
Pathway
hsa04150  mTOR signaling pathway
Network
nt06522 mTOR signaling
Gene
MTOR [HSA:2475] [KO:K07203]
Other DBs
ICD-11: LD90.Y
OMIM: 616638
Reference
  Authors
Gordo G, Tenorio J, Arias P, Santos-Simarro F, Garcia-Minaur S, Moreno JC, Nevado J, Vallespin E, Rodriguez-Laguna L, de Mena R, Dapia I, Palomares M, Del Pozo A, Ibanez K, Silla JC, Barroso E, Ruiz Perez VL, Martinez-Glez V, Lapunzina P
  Title
mTOR mutations in Smith-Kingsmore syndrome: Four additional patients and a review.
  Journal
Clin Genet 93:762-775 (2018)
DOI:10.1111/cge.13135
Reference
PMID:27753196 (mTOR)
  Authors
Moosa S, Bohrer-Rabel H, Altmuller J, Beleggia F, Nurnberg P, Li Y, Yigit G, Wollnik B
  Title
Smith-Kingsmore syndrome: A third family with the MTOR mutation c.5395G>A p.(Glu1799Lys) and evidence for paternal gonadal mosaicism.
  Journal
Am J Med Genet A 173:264-267 (2017)
DOI:10.1002/ajmg.a.37999
LinkDB

» Japanese version

KEGG   DISEASE: Focal cortical dysplasia of Taylor
Entry
H01251                      Disease                                
Name
Focal cortical dysplasia of Taylor;
Focal cortical dysplasia type II
Description
Focal cortical dysplasia of Taylor (FCDT) is a subtype of cortical displasias. FCDT is characterized by epilepsy associated malformations that are often composed of balloon cells and dysplastic neurons. It has been found that inherited mutations in the TSC1 gene can cause this disorder.
Category
Congenital malformation
Brite
Human diseases in ICD-11 classification [BR:br08403]
 20 Developmental anomalies
  Structural developmental anomalies primarily affecting one body system
   Structural developmental anomalies of the nervous system
    LA05  Cerebral structural developmental anomalies
     H01251  Focal cortical dysplasia of Taylor
Pathway-based classification of diseases [BR:br08402]
 Signal transduction
  nt06522  mTOR signaling
   H01251  Focal cortical dysplasia of Taylor
Pathway
hsa04150  mTOR signaling pathway
hsa04151  PI3K-Akt signaling pathway
hsa04910  Insulin signaling pathway
hsa04140  Autophagy - animal
Network
nt06522 mTOR signaling
Gene
MTOR [HSA:2475] [KO:K07203]
TSC1 [HSA:7248] [KO:K07206]
TSC2 [HSA:7249] [KO:K07207]
Other DBs
ICD-11: LA05.51
MeSH: C537067
OMIM: 607341
Reference
  Authors
Tassi L, Colombo N, Garbelli R, Francione S, Lo Russo G, Mai R, Cardinale F, Cossu M, Ferrario A, Galli C, Bramerio M, Citterio A, Spreafico R
  Title
Focal cortical dysplasia: neuropathological subtypes, EEG, neuroimaging and surgical outcome.
  Journal
Brain 125:1719-32 (2002)
DOI:10.1093/brain/awf175
Reference
PMID:25799227 (mTOR)
  Authors
Lim JS, Kim WI, Kang HC, Kim SH, Park AH, Park EK, Cho YW, Kim S, Kim HM, Kim JA, Kim J, Rhee H, Kang SG, Kim HD, Kim D, Kim DS, Lee JH
  Title
Brain somatic mutations in MTOR cause focal cortical dysplasia type II leading to intractable epilepsy.
  Journal
Nat Med 21:395-400 (2015)
DOI:10.1038/nm.3824
Reference
PMID:19918125 (TSC1 TSC2)
  Authors
Lugnier C, Majores M, Fassunke J, Pernhorst K, Niehusmann P, Simon M, Nellist M, Schoch S, Becker A
  Title
Hamartin variants that are frequent in focal dysplasias and cortical tubers have reduced tuberin binding and aberrant subcellular distribution in vitro.
  Journal
J Neuropathol Exp Neurol 68:1136-46 (2009)
DOI:10.1097/NEN.0b013e3181b9a699
LinkDB

» Japanese version

DBGET integrated database retrieval system